1.	Omega 3 FA Supplements as Augmentation in the Treatment of Depression Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: OmegaDVS, NCT01803711
2.	Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: SCUSF 0806, 5U10CA081920-11, HLMCC-0806, NCT01009918
3.	Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Congestive Heart Failure (PREVENT-CHF): A Phase IIB Randomized Placebo-Controlled Trial Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 16 and over Sponsor: NCI, Other Protocol IDs: 11018, NCI-2011-00717, K12CA001727, NCT01347970
4.	Proton Therapy for Lymph Nodes in Breast Cancer Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UFPTI 1016-BR01, NCT01365845
5.	Statin Therapy in Young Adult Survivors of Childhood Cancer Phase: Phase II Type: Supportive care Status: Active Age: 18 to 39 Sponsor: Other Protocol IDs: 1207M17202, NCT01733953
6.	Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer Phase: Phase I Type: Supportive care, Treatment Status: Active Age: 21 and over Sponsor: NCI Protocol IDs: AAAD8521, NCT00976131
7.	Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MCC-13419, NCI-2011-0098, NCT01375699
8.	A Study to Look at the Electrical Activity of the Heart in Subjects With Solid Tumor Cancers, Before and After Receiving the Study Treatment, GSK1120212 Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 114655, NCT01658553
9.	Effect of Tivantinib on the QTC Interval in Cancer Subjects Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: ARQ197-A-U-159, NCT01699061
10.	A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 113773, NCT01738451
11.	Exercise and Relaxation Intervention for Young Adult Cancer Survivors Phase: No phase specified Type: Behavioral study, Supportive care Status: Active Age: 18 to 39 Sponsor: Other Protocol IDs: 09-091-01-CPPB, MRSG-09-091-01-CPPB, NCT00801008
12.	Studying Biomarkers in Detecting Heart Damage in Patients Receiving Chemotherapy Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 to 85 Sponsor: NCI, Other Protocol IDs: CDR0000660615, MDA-2007-0914A, 2007-0914A, NCT01032278
13.	Women With Cancer: An Exercise Study to Promote Health Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: 0801003383, 1R01CA122658-01A2, NCT01102985
14.	Exercise Program for Early Breast Cancer Survivors Phase: No phase specified Type: Educational/Counseling/Training, Supportive care Status: Active Age: Not specified Sponsor: NCI, Other Protocol IDs: 1B-12-1, NCI-2010-01265, NCT01140282
15.	Patients Undergoing Major Cancer Surgery: Incidence and Predictive Value for Postoperative Cardiac Events Phase: No phase specified Type: Supportive care Status: Active Age: 50 and over Sponsor: Other Protocol IDs: 10-206, NCT01262222
16.	A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: P10-3, NCT01306890
17.	Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 10-205, NCT01340495
18.	Cardiovascular Effects of Sunitinib Therapy (CREST) Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UPCC 34810, NCT01370109
19.	Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-140, NCT01453660
20.	Ultrasound and Other Images of Artery Blockages Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 21 and over Sponsor: NHLBI Protocol IDs: 110224, 11-H-0224, NCT01419574
21.	Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery Phase: No phase specified Type: Diagnostic, Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CCCWFU 74111, NCI-2011-02361, NCT01483196
22.	Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy Phase: No phase specified Type: Supportive care Status: Active Age: 9 to 35 Sponsor: Other Protocol IDs: CardiacMRI, NCT01671696
23.	RITHM - Resonance Imaging Trial for Heart Biomarkers in Adolescent/Young (AYA) Cancer Survivors Phase: No phase specified Type: Supportive care Status: Active Age: 16 to 40 Sponsor: Other Protocol IDs: CCCWFU 99312, NCT01719094
24.	MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy Phase: No phase specified Type: Diagnostic, Supportive care Status: Active Age: 22 and over Sponsor: NCI, Other Protocol IDs: CCCWFU 99112, NCI-2012-01613, P30CA012197, NCT01719562
25.	A Web-Based Physical Activity Intervention in Adolescent Survivors of Childhood Cancer Phase: No phase specified Type: Supportive care Status: Active Age: 11 to 14 Sponsor: Other Protocol IDs: ZAMZEE, 1 R21HD077235, NCT01778127